Innate Immunity in Cancer Biology and Therapy
Open Access
- 8 July 2023
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (14) , 11233
Abstract
Immunotherapies including adaptive immune checkpoint inhibitors (ICIs) and chimeric antigen receptor (CAR) T cells, have developed the treatment of cancer in clinic, and most of them focus on activating T cell immunity. Although these strategies have obtained unprecedented clinical responses, only limited subsets of cancer patients could receive long-term benefits, highlighting the demand for identifying novel targets for the new era of tumor immunotherapy. Innate immunity has been demonstrated to play a determinative role in the tumor microenvironment (TME) and influence the clinical outcomes of tumor patients. A thorough comprehension of the innate immune cells that infiltrate tumors would allow for the development of new therapeutics. In this review, we outline the role and mechanism of innate immunity in TME. Moreover, we discuss innate immunity-based cancer immunotherapy in basic and clinical studies. Finally, we summarize the challenges in sufficiently motivating innate immune responses and the corresponding strategies and measures to improve anti-tumor efficacy. This review could aid the comprehension of innate immunity and inspire the creation of brand-new immunotherapies for the treatment of cancer.Keywords
Funding Information
- National Natural Science Foundation of China (32200745, 82073752, 81773620, 82002915, 21YF1401900, 20YF1402800, 20S11904700, 20JC1411000, 20S11906100)
- Shanghai Sailing Program (32200745, 82073752, 81773620, 82002915, 21YF1401900, 20YF1402800, 20S11904700, 20JC1411000, 20S11906100)
- Scientific and Innovative Action Plan of Shanghai (32200745, 82073752, 81773620, 82002915, 21YF1401900, 20YF1402800, 20S11904700, 20JC1411000, 20S11906100)
This publication has 142 references indexed in Scilit:
- Innate lymphoid cells sustain colon cancer through production of interleukin-22 in a mouse modelJournal of Experimental Medicine, 2013
- Usefulness of Pretreatment Neutrophil to Lymphocyte Ratio in Predicting Disease-Specific Survival in Breast Cancer PatientsJournal of Breast Cancer, 2013
- Tumor-infiltrating DCs suppress nucleic acid–mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1Nature Immunology, 2012
- The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumorsProceedings of the National Academy of Sciences, 2012
- Chemokine nitration prevents intratumoral infiltration of antigen-specific T cellsJournal of Experimental Medicine, 2011
- Development of an attenuated interleukin-2 fusion protein that can be activated by tumour-expressed proteasesImmunology, 2011
- Immunity, Inflammation, and CancerCell, 2010
- Hierarchy of immunosuppressive strength among myeloid‐derived suppressor cell subsets is determined by GM‐CSFEuropean Journal of Immunology, 2009
- Effect of Granulocyte/Macrophage Colony-Stimulating Factor on Vaccination with an Allogeneic Whole-Cell Melanoma VaccineClinical Cancer Research, 2009
- In vivo kinetics of human natural killer cells: the effects of ageing and acute and chronic viral infectionImmunology, 2007